| Ytd | -84.50% | |
| 1y | -95.82% |
| Open | 2.30 | Prev Close | 2.31 | Low | 2.20 | High | 2.33 | Mkt Cap | 2.21M |
| Vol | 65.39K | Avg Vol | 222.52K | EPS | -64.40 | P/E | N/A | Forward P/E | -0.98 |
| Beta | -0.18 | Short Ratio | 1.62 | Inst. Own | 36.40% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-10 | 50-d Avg | 4.17 | 200-d Avg | 11.84 | 1yr Est | 2.50 |
XAIR News
Beyond Air (NASDAQ:XAIR) affirms FY2027 sales outlook from $16.000 million-$18.000 million to $16.00
Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial-stage
Preliminary revenue of $2.3 million represents the highest quarterly revenue reported, and approxima
https://x.com/US_Patent_Plays/status/2103212175091200022https://ppubs.uspto.gov/pubwebapp/external.h
Gainers Milestone Scientific (AMEX:MLSS) stock moved upwards by 11.8% to $0.44 during Monday's
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) shares rose 25.3% to $2.08 during Friday's afte
GARDEN CITY, N.Y., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial-
Gainers Intelligent Bio Solutions (NASDAQ:INBS) stock moved upwards by 8.2% to $2.63 during Tuesday
Lake Street analyst Frank Takkinen initiates coverage on Beyond Air (NASDAQ:XAIR) with a Buy rati
Gainers Redhill Biopharma (NASDAQ:RDHL) shares increased by 96.7% to $1.3 during Monday's pre-m
Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial-stage
GARDEN CITY, N.Y., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" o
Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 24.6% to $6.42 during Friday's regular
Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 41.4% to $7.29 during Friday's pre-mark
Elastic NV (ESTC) stock rose 21.8% in pre-market trading after reporting strong Q1 results and raisi
Gainers Aethlon Medical (NASDAQ:AEMD) stock rose 50.7% to $3.27 during Thursday's after-market
https://ipsearch.ipaustralia.gov.au/patents/2020393170
Gainers Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 35.9% to $7.3 during Tuesday's
Beyond Air to receive shares representing 19.99% of Univo's issued and outstanding share capital
Beyond Air to receive shares representing 19.99% of Univo's issued and outstanding share capital upo
Beyond Air, Inc. (XAIR) Q1 2027 Earnings Call Transcript
Beyond Air (NASDAQ:XAIR) reported quarterly losses of $(11.00) per share which missed the analyst co
Beyond Air (NASDAQ:XAIR) affirms FY2027 sales outlook from $16.000 million-$18.000 million to $16.00
Reports $1.8 million revenue for quarter ended June 30, 2026; reaffirms revenue guidance of $8 milli
GARDEN CITY, N.Y., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” o
Gainers Universe Pharmaceuticals (NASDAQ:UPC) shares increased by 108.5% to $6.59 during Monday'
VANCOUVER, British Columbia, July 30, 2026 (GLOBE NEWSWIRE) -- Beyond Oil Ltd. (TSX: BOIL) (OTCQB: B
GARDEN CITY, N.Y., July 30, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” o
Gainers Anixa Biosciences (NASDAQ:ANIX) shares rose 10.0% to $3.65 during Friday's pre-market s
Gainers Liminatus Pharma (NASDAQ:LIMN) stock increased by 40.9% to $0.16 during Thursday's pre-
Beyond Air, Inc. (XAIR) Q4 2026 Earnings Call Transcript
U.S. stock futures slipped on Friday after a mixed close on Thursday.
On Friday, Beyond Air (NASDAQ:XAIR) discussed fourth-quarter financial results during its earnings c
Companies Reporting Before The Bell • Beyond Air (NASDAQ:XAIR) is estimated to report quarterly loss
Beyond Air (NASDAQ:XAIR) reported quarterly losses of $(0.77) per share which missed the analyst con
Revenue increased by 107% year-over-year to $7.7 million in the full fiscal year 2026; increased rev
The CNN Fear & Greed Index, measuring market sentiment, showed a slight decline on Thursday, rem
U.S. stock futures are down, but some stocks to watch today include Apogee, BitGo, Cineverse, Synapt
GARDEN CITY, N.Y., June 22, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” o
Special Meeting of Stockholders Scheduled for June 18, 2026 at 4:30 p. m. Eastern Time Proxies have
Beyond Air, Inc. (NASDAQ:XAIR), a commercial-stage medical device and biopharmaceutical company focu
GARDEN CITY, N.Y., June 01, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial-s
The Phase 1 trial (NCT05351502) was a clinical proof-of-concept trial that assessed the intratumoral
Updated AACR poster data show continued survival follow-up in heavily pre ‑ treated patients followi
https://x.com/PatentGrants/status/2045229993731776669
GARDEN CITY, N.Y., April 15, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial-